This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical effects

Authoring team

The effects of serotonin can be divided up according to target tissues:

  • blood vessels:
    • the overall effect is dependent on vessel size, distribution of receptors, and modulation of noradrenergic output
    • conductance vessels tend to constrict
    • transfer vessels: arterioles dilate, venules constrict and capillaries become more permeable; this favours the formation of oedema in the inflammatory response
  • central nervous system:
    • involved in sleep induction
    • involved in vascular tone: underpin agonists use in cluster headache and migraine
    • involved in mood: the basis of using selective serotonin uptake inhibitors
    • facilitates firing of motorneurons
    • involved in ability to differentiate sensory phenomena; reduction of its effect e.g. with the antagonist LSD, contributes to hallucinogenesis
    • involved in temperature regulation in the hypothalamus
  • gastrointestinal tract:
    • contraction due to direct stimulation of smooth muscle and indirect inhibition of noradrenergic input
    • stimulus for release includes vagus nerve and physical displacement of chromaffin cells
  • free nerve endings: pain, possible role in acute inflammation

Drugs which influence the serotonergic system include methysergide, sumatriptan, ketanserin, odansetron and the serotonin selective reuptake inhibitors.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.